UTHRNasdaqSEC EDGAREDGAR

UNITED THERAPEUTICS Corp

Pharmaceutical Preparations·SILVER SPRING, MD·FY end 12/31·CIK 1082554

Board of Directors

13 members · 12 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
Christopher CauseyDirector21y63NCGAudit—
Richard GiltnerDirector15y62AuditNCG—
Ray KurzweilDirector22y78——
Jan MalcolmDirector0y70Audit—
Linda MaxwellDirector4y52CompNCG—
Nilda MesaDirector6y66CompNCG—
Judy OlianDirector9y74Audit—
Christopher PatuskyLead Independent Director22y62CompNCG—
Martine RothblattChair28y71———
Louis SullivanDirector22y92Comp—
Tommy ThompsonDirector14y84Audit—
Kevin TraceyDirector0y68——
Raymond DwekDirector——Comp—

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.